JPRN-UMIN000004778已完成2 期
Efficacy of sitafloxacin as third-line eradication treatment of Helicobacter pylori - Helicobacter pylori rescue therapy by sitafloxacin
ational Organization Tokyo medical center0 个研究点目标入组 30 人开始时间: 2011年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient with severe heart failure, renal failure or infection. 2. Patients with allergy for rabeprazole, amoxicillin or sitafloxacin. 3. Pregnant patient.
研究者
相似试验
已完成
不适用
Evaluation of efficacy of Sitafloxacin in treatment of moderate to severe acute rhinosinusitisacute rhinosinusitisJPRN-UMIN000009567Wakayama-Okayama Otolaryngology Pharma100
招募中
不适用
Efficacy of sitafloxacin for urinary tract infectioJPRN-jRCTs061200052Takehiro Iwata92
已完成
不适用
Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.peritonsillar abcessJPRN-UMIN000013812Saitama Medical University20
已完成
2 期
Efficacy and safety of sitafloxacin (STFX) for low-risk febrile neutropenia in patients with lung cancer, phase II study,JPRN-UMIN000010911ung Oncology Group in Kyushu, Japan (LOGIK)54
已完成
不适用
Clinical trial of sitafloxacin against non-gonococcal urethritison-gonococcal urethritisJPRN-UMIN000004509PO CREC net500